ArticleDiagnostic pathology2015

PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway.

Xiang-Rong Shu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.